Folgen
Dr. Moritz Völker-Albert
Dr. Moritz Völker-Albert
Co-founder EpiQMAx GmbH
Bestätigte E-Mail-Adresse bei epiqmax.de
Titel
Zitiert von
Zitiert von
Jahr
ZMYND8 co-localizes with NuRD on target genes and regulates poly (ADP-ribose)-dependent recruitment of GATAD2A/NuRD to sites of DNA damage
CG Spruijt, MS Luijsterburg, R Menafra, RGH Lindeboom, PWTC Jansen, ...
Cell reports 17 (3), 783-798, 2016
992016
Forschungsethik: Eine Einführung
M Fuchs, T Heinemann, B Heinrichs, D Hübner, J Kipper, K Rottländer, ...
Springer-Verlag, 2016
442016
Domain model explains propagation dynamics and stability of histone H3K27 and H3K36 methylation landscapes
C Alabert, C Loos, M Voelker-Albert, S Graziano, I Forné, ...
Cell reports 30 (4), 1223-1234. e8, 2020
422020
PWWP2A binds distinct chromatin moieties and interacts with an MTA1-specific core NuRD complex
S Link, RMM Spitzer, M Sana, M Torrado, MC Völker-Albert, EC Keilhauer, ...
Nature Communications 9 (1), 4300, 2018
402018
Proteome dynamics at broken replication forks reveal a distinct ATM-directed repair response suppressing DNA double-strand break ubiquitination
K Nakamura, G Kustatscher, C Alabert, M Hödl, I Forne, M Völker-Albert, ...
Molecular Cell 81 (5), 1084-1099. e6, 2021
352021
Endotoxinemia accelerates atherosclerosis through electrostatic charge–mediated monocyte adhesion
A Schumski, A Ortega-Gómez, K Wichapong, C Winter, P Lemnitzer, ...
Circulation 143 (3), 254-266, 2021
352021
Forschungsethik
M Fuchs, T Heinemann, B Heinrichs, D Hübner, J Kipper, K Rottländer, ...
JB Metzler, 2010
202010
Analysis of histone modifications by mass spectrometry
MC Völker‐Albert, A Schmidt, I Forne, A Imhof
Current Protocols in Protein Science 92 (1), e54, 2018
192018
Functional Analysis of Missense Variants in the Putative Breast Cancer Susceptibility Gene XRCC2
FS Hilbers, MS Luijsterburg, WW Wiegant, CM Meijers, M Völker‐Albert, ...
Human Mutation 37 (9), 914-925, 2016
142016
A novel proteomics approach to epigenetic profiling of circulating nucleosomes
P Van den Ackerveken, A Lobbens, JV Turatsinze, V Solis-Mezarino, ...
Scientific reports 11 (1), 1-12, 2021
122021
Histone modifications in stem cell development and their clinical implications
M Völker-Albert, A Bronkhorst, S Holdenrieder, A Imhof
Stem Cell Reports 15 (6), 1196-1205, 2020
102020
A quantitative proteomic analysis of in vitro assembled chromatin
MC Völker-Albert, MC Pusch, A Fedisch, P Schilcher, A Schmidt, A Imhof
Molecular & Cellular Proteomics 15 (3), 945-959, 2016
102016
Theorie der Ethik
D Hübner
Forschungsethik. Eine Einführung. JB Metzler, Stuttgart. https://www. philos …, 2010
92010
New Approaches for Absolute Quantification of Stable‐Isotope‐Labeled Peptide Standards for Targeted Proteomics Based on a UV Active Tag
K Schnatbaum, V Solis‐Mezarino, D Pokrovsky, F Schäfer, D Nagl, ...
Proteomics 20 (10), 2000007, 2020
72020
Determining histone H4 acetylation patterns in human peripheral blood mononuclear cells using mass spectrometry
EM Bux, V Solis-Mezarino, C Kuhm, BH Northoff, I Karin, T Klopstock, ...
Clinical Mass Spectrometry 15, 54-60, 2020
62020
Forschung und Gesellschaft
T Heinemann, M Fuchs, T Heinemann, B Heinrichs, D Hübner, J Kipper, ...
Forschungsethik. Eine Einführung 98, 119, 2010
42010
Detection of histone modification dynamics during the cell cycle by MS-based proteomics
MC Völker-Albert, A Schmidt, TK Barth, I Forne, A Imhof
Histone Variants: Methods and Protocols, 61-74, 2018
32018
Data on the kinetics of in vitro assembled chromatin
MC Völker-Albert, MC Pusch, A Schmidt, A Imhof
Data in brief 8, 353-359, 2016
32016
Front Cover: New Approaches for Absolute Quantification of Stable‐Isotope‐Labeled Peptide Standards for Targeted Proteomics Based on a UV Active Tag
K Schnatbaum, V Solis‐Mezarino, D Pokrovsky, F Schäfer, D Nagl, ...
Proteomics 20 (10), 2070081, 2020
12020
Domain model explains propagation dynamics and stability of K27 and K36 methylation landscapes
C Alabert, C Loos, M Voelker-Albert, S Graziano, I Forné, ...
bioRxiv, 729905, 2019
2019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20